Medtronic Neuromodulation recalls Vanta Implantable Neurostimulator (INS), Model 977006

Recall date

August 21, 2024

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

Z-0132-2025

FDA classification

Class II

Brand / firm

Medtronic Neuromodulation

Sold / distributed

Worldwide distribution.

Why it was recalled

Model 977006 Vanta INS batterty life has depleted faster than HCPs or patients expected leading to outpatient reprogramming or earlier than anticipated surgical replacements.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Vanta Implantable Neurostimulator (INS), Model 977006